Status:
UNKNOWN
Intermittent Fasting in Dyslipidemia
Lead Sponsor:
Aga Khan University
Conditions:
Intermittent Fasting
Dyslipidemias
Eligibility:
All Genders
18-80 years
Phase:
NA
Brief Summary
World Health Organization report notifies of the escalating global burden of cardiovascular diseases (CVD), projecting that it will become the major worldwide cause of death and disability by 2020. Th...
Detailed Description
INTRODUCTION: Overall lipid profile is important in cardiovascular diseases but particularly serum HDL levels have long been recognized as an independent inverse prognostic marker of CVD, when the Fr...
Eligibility Criteria
Inclusion
- General population with serum HDL less than 40 mg/dl for men and women
- Adult ages 18- 80 years will be included in the study.
Exclusion
- Individuals Patients already observing fasting regularly
- Pregnant women and individuals with diabetes, metabolic syndrome or any other co-morbidity will be excluded.
Key Trial Info
Start Date :
February 20 2019
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
September 15 2019
Estimated Enrollment :
60 Patients enrolled
Trial Details
Trial ID
NCT03805776
Start Date
February 20 2019
End Date
September 15 2019
Last Update
February 21 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Aga Khan University
Karachi, Sindh, Pakistan, 74800